Philip Lee advised Locomotive on the deal. Locomotive completed the acquisition of Galway-based digital marketing firm IMS Marketing, strengthening Locomotive’s international footprint. IMS Marketing B2B marketing...
You must be a Standard 1 Year member to access this content.
Philip Lee advised the senior management team of Premier Lotteries Ireland DAC on the deal. French company La Française des Jeux, known as FDJ is to...
You must be a Standard 1 Year member to access this content.
Philip Lee advised the shareholders of Innopharma Education & Technical Services on the deal. The shareholders of Innopharma Education & Technical Services announced a strategic investment...
You must be a Standard 1 Year member to access this content.
Philip Lee advised Irish company Brera Holdings PLC. Brera Holdings PLC concluded the initial public offering (IPO) of the company on the Nasdaq. Brera Holdings PLC...
You must be a Standard 1 Year member to access this content.
Proskauer and William Fry advised CBPE Capital, while Philip Lee advised Snigel on the deal. CBPE Capital LLP executed its investment into Snigel, a leading advertising...
You must be a Standard 1 Year member to access this content.
Philip Lee advised Scientific Laboratory Supplies on the deal. BHSM LLP acted for the shareholders of Sparks Lab Supplies Limited. Scientific Laboratory Supplies (SLS), the UK’s...
You must be a Standard 1 Year member to access this content.
Philip Lee advised Wrkit. Irish founded employee engagement platform Wrkit and its entire product set has been sold to British employee benefits software company Benefex. Benefex,...
You must be a Standard 1 Year member to access this content.
Philip Lee advised Crow Rock Capital on this investment. Leading digital therapeutics company HealthBeacon has raised €6 million from Elkstone and Crow Rock Capital to bring...
You must be a Standard 1 Year member to access this content.
Philip Lee provided Irish law advice to OQEMA on the transaction. German chemical distributor OQEMA has acquired Casoria in Ireland. The acquisition will expand OQEMA’s presence...
You must be a Standard 1 Year member to access this content.
Philip Lee advised Novellus on the deal. Brooklyn ImmunoTherapeutics has completed its acquisition of engineered cellular medicine company Novellus Therapeutics Limited. This acquisition advances Brooklyn’s evolution...
You must be a Standard 1 Year member to access this content.
